| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| daxalipram | phosphodiesterase 4a | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
NA | discontinued in phase 2 | unknown |
| daxalipram | phosphodiesterase 4b | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
NA | discontinued in phase 2 | unknown |
| daxalipram | camp-specific 3',5'-cyclic phosphodiesterase 4b | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
NA | experimental | unknown |
| daxalipram | phosphodiesterase 4d | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
NA | discontinued in phase 2 | unknown |
| click here to return to the previous page | ||||||||